Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-27T01:58:15.734Z Has data issue: false hasContentIssue false

A Self-assembled, Drug-deliverable Nanomaterial for Cartilage Tissue Engineering

Published online by Cambridge University Press:  01 February 2011

Yupeng Chen
Affiliation:
[email protected], Brown University, Providence, Rhode Island, United States
Hicham Fenniri
Affiliation:
[email protected], National Research Council and University of Alberta, Edmonton, Canada
Thomas J. Webster
Affiliation:
[email protected], Brown University, Providence, Rhode Island, United States
Get access

Abstract

The current clinical treatment of cartilage defects involves autologous chondrocyte implantation into cartilage defect sites. However, one of the complications associated with this method is the lack of bonding between the implanted materials and natural tissue. Helical rosette nanotubes (HRNs) are novel biomimetic self-assembled supramolecular structures whose basic building blocks are DNA base-pairs. HRNs are similar in size to collagen in cartilage. Moreover, previous studies have shown that HRNs are biocompatible and increase the adhesion of numerous cells compared to other commonly used cartilage implant materials (like hydrogels and Ti). In addition, HRNs can solidify into a viscous gel at body temperatures under short periods of time. Thus, it is hoped that HRNs can serve as a novel in situ tissue implant to improve cartilage cell adhesion and functions. In this study, in order to heal cartilage rupture and regenerate cartilage during possible implantation, the mechanical properties of select hydrogel/HRN composites were tested. In addition, electro-spinning was used to generate three-dimensional, implantable, composite fibers encapsulated with chondrocytes and fibroblast-like type-B synoviocytes (SFB cells, a type of mesenchymal stem cell). Importantly, results showed that drug-delivered HRNs enhanced hydrogel adhesive strength and created a scaffold with nanometer-rough surface structures pertinent for cartilage regeneration. In this manner, this study provided an alternative cartilage regenerative material which relies on nanotechnology that can be injected as a liquid, solidify at body temperatures under short periods of time, have suitable mechanical properties to collagen, and promote cell functions.

Type
Research Article
Copyright
Copyright © Materials Research Society 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Tuan, RS, Boland, G, Tuli, R., Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Research and Therapy, 2002, 5, 3245.Google Scholar
2. PR, Newswire, Milestone Scientific Signs Agreement With Carticept Medical to Collaborate on CompuFlo(TM) Injection System for Treatment of Arthritic Joints, 2007.Google Scholar
3. Langer, R, Vacanti, JP. Tissue engineering. Science 1993; 260: 920926.Google Scholar
4. Temenoff, JS, Mikos, AG. Review: tissue engineering for regeneration of articular cartilage. Biomaterials 2000; 21: 431440.Google Scholar
5. Brittberg, M, Lindahl, A, Nilsson, A, Ohlsson, C, Isaksson, O, Peterson, L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994; 331: 889895.Google Scholar
6. Puelacher, WC, Mooney, D, Langer, R, Upton, J, Vacanti, JP, Vacanti, CA. Design of nasoseptal cartilage replacements synthesized from biodegradable polymers and chondrocytea Biomaterials 1994; 15:774–778.Google Scholar
7. Freed, LE, Marquis, JC, Nohria, A, Emmanual, J, Mikos, AG, Langer, R. Neocartilage formation IN VITRO and IN VIVO using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res 1993; 27:11–23.Google Scholar
8. Grande, DA, Halberstadt, C, Naughton, G, Schwartz, R, Manji, R., Evaluation of matrix scaffolds for tissue engineering of articular cartilage grafts. J Biomed Mater Res 1997; 34: 211220.Google Scholar
9. Nehrer, S, Breinan, HA, Ramappa, A, Shortkroff, S, Young, G, Minas, T, Sledge, CB, Yannas, IV, Spector M.Canine chondrocytes seeded in type I and type II collagen implants investigated in vitro. J Biomed Mater Res 1997; 38: 95104.Google Scholar
10. Brun, P, Abatangelo, G, Radice, M, Zacchi, V, Guidolin, D, Daga Gordini, D, Cortivo, R. Chondrocyte aggregation and reorganization into three-dimensional scaffolds. J Biomed Mater Res 1999; 46: 337346.Google Scholar
11. Chun, AL, Moralez, J G, Fenniri, H, Webster, TJ. Helical rosette nanotubes: a biomimetic coating for orthopedics? Biomaterials 2005; 26: 7304–7309.Google Scholar
12. Chun, AL, Moralez, J G, Fenniri, H, Webster, TJ. Helical rosette nanotubes: A more effective orthopaedic implant material. Nanotechnology 2004; 15: s234–s239.Google Scholar
13. Fenniri, H, mathivanan, P, Vidale, KL, Sherman, DM, Hallenga, K, wood, KV and Stowell, JG. Helical rosette nanotubes: design, self-assembly and characterization. J.Am. Chem.Soc. 2001, 123, 38543855.Google Scholar
14. Eslaminejad, MB, Mirzadeh, H, Mohamadi, Y, Nickmahzar, A. Bone differentiation of marrow-derived mesenchymal stem cells using beta-tricalcium phosphate-alginate-gelatin hybrid scaffolds. J Tissue Eng Regen Med. 2007 Nov-Dec; 1(6):417424.Google Scholar
15. Kurth, T, Hedbom, E, Shintani, N, Sugimoto, M, Chen, FH, Haspl, M, Martinovic, S, Hunziker, EB. Chondrogenic potential of human synovial mesenchymal stem cells in alginate. Osteoarthritis Cartilage. 2007 Oct; 15(10):11781189.Google Scholar